IQVIA Holdings

Previously known as Quintiles IMS Health, IQVIA Holdings is offering health and medical information and technological solutions as well as analyzing data that will be useful for product creation.  While this sector caters to the medical field, it was adversely affected by the pandemic when its stocks plummeted to less than $100 in April 2020.

Hedge fund HealthCor Management, however, still believes in IQVIA and increased its stake by 54 percent in the third quarter of 2020. In February 2021, shares ballooned to over $191, outperforming its rivals Thermo Fisher Scientific Inc. and Charles River Laboratories International Inc.